Japan Depression Screening Market to 2032
Overview
The Japan Depression Screening Market is expected to reach a 299.56 USD Million by 2032 and is projected to grow at a CAGR of 12.98% from 2025 to 2032.
Revenue, 2024 (USD Million)
127.51
Forecast, 2032 (USD Million)
299.56
CAGR, 2024 - 2032
12.98%
Report Coverage
Japan
Japan Depression Screening Market 2018-2032 USD Million
Japan Depression Screening Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 127.51 USD Million
- Projected Market Size (2032): 299.56 USD Million
- CAGR (2025-2032): 12.98%
Key Findings of Japan Depression Screening Market
- The Japan Depression Screening Market was valued at 127.51 USD Million in 2024.
- The Japan Depression Screening Market is likely to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Major Depressive Disorder (MDD) in Depression Type Segment accounted for the largest share of the market with a revenue of 82.81 USD Million
- The fastest growing segment Lab Tests in Diagnosis Segment grew Fastest with a CAGR of 13.64% during the forecast period from 2024 to 2032.
Japan Depression Screening Market Scope
Japan Depression Screening Market Segmentation & Scope
End-User
- Medical Research Centers
- Others
- Specialty Clinics
- Hospital
Diagnosis
- Lab Tests
- Screening
Depression Type
- Others
- Persistent Depressive Disorder (PDD)
- Major Depressive Disorder (MDD)
Japan Depression Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 127.51 USD Million |
| Market Value in 2032 | 299.56 USD Million |
| CAGR (2025-2032) | 12.98% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End-User,Diagnosis,Depression Type |
Regional Insights:
-
Leading Market (2024-2032): Japan, leading in terms of revenue 127.51 USD Million in 2024
- Key Country: Japan, leading in terms of revenue with value of 127.51 USD Million in 2024.
Segments and Scope
-
Japan Depression Screening Market to 2032, By End-User
- Hospital is the largest segment in Japan Depression Screening Market to 2032 with a revenue of 60.26 USD Million in the year 2024.
- Hospital is the Fastest growing segment in Japan Depression Screening Market to 2032 with a Growth rate of 13.32 % in forecast period 2025-2032.
-
Japan Depression Screening Market to 2032, By Diagnosis
- Screening is the largest segment in Japan Depression Screening Market to 2032 with a revenue of 81.80 USD Million in the year 2024.
- Lab Tests is the Fastest growing segment in Japan Depression Screening Market to 2032 with a Growth rate of 12.59 % in forecast period 2025-2032.
-
Japan Depression Screening Market to 2032, By Depression Type
- Major Depressive Disorder (MDD) is the largest segment in Japan Depression Screening Market to 2032 with a revenue of 82.81 USD Million in the year 2024.
- Major Depressive Disorder (MDD) is the Fastest growing segment in Japan Depression Screening Market to 2032 with a Growth rate of 13.28 % in forecast period 2025-2032.
Japan Depression Screening Market Company Share Analysis
| Company Name |
|
||
| Koninklijke Philips N.V. | |||
| Apple Inc. | |||
| Lifetrack Medical Systems | |||
Japan Depression Screening Market Geographical Sales Distribution, 2018-2032 USD Million
Japan Depression Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Japan Depression Screening Market is segmented based on Segmentation End-User,Diagnosis,Depression Type.
Japan Depression Screening Market was valued at USD 127.51(Revenue in USD Million) in 2023.
Japan Depression Screening Market is projected to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
The Major Depressive Disorder (MDD) segment is expected to dominate the Japan Depression Screening Market, holding a largest market share of 82.81 USD Million in 2024
Japan Depression Screening Market Scope
Japan Depression Screening Market Segmentation & Scope
End-User
- Medical Research Centers
- Others
- Specialty Clinics
- Hospital
Diagnosis
- Lab Tests
- Screening
Depression Type
- Others
- Persistent Depressive Disorder (PDD)
- Major Depressive Disorder (MDD)
Frequently Asked Questions
The Japan Depression Screening Market is segmented based on Segmentation End-User,Diagnosis,Depression Type.
Japan Depression Screening Market was valued at USD 127.51(Revenue in USD Million) in 2023.
Japan Depression Screening Market is projected to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
The estimated market value of the Japan Depression Screening Market for final year is USD 299.56 (USD Million).
Japan Depression Screening Market Company Profiling
Frequently Asked Questions
The Japan Depression Screening Market is segmented based on Segmentation End-User,Diagnosis,Depression Type.
Japan Depression Screening Market was valued at USD 127.51(Revenue in USD Million) in 2023.
Japan Depression Screening Market is projected to grow at a CAGR of 12.98% during the forecast period of 2024 to 2032.
The estimated market value of the Japan Depression Screening Market for final year is USD 299.56 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.